Sponsor Pipeline

Zulfa Omer Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06978088 LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma… Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recruiting
NCT07014917 Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL Chronic Lymphocytic Leukemia Recruiting
NCT07108998 Study of Epcoritamab as a Consolidation Therapy in CLL/SLL CLL/SLL Recruiting
Disease Areas
Leukemia (3) Chronic Lymphocytic Leukemia (CLL) (3)
Get alerts when Zulfa Omer's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free